Abstract Details

Title Copper Complexing with Tetrathiomolybdate Suppresses Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Topic Aging and Dementia

Presentation(s) (-)

Poster/Presentation
Number 009

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Joseph F. Quinn, MD, FAAN (OHSU Neurology)	Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Refujia Gomez	Refujia Gomez has nothing to disclose.
Alfonso Iudice	No disclosure on file

��ɫ��